Pro Medicus Limited

ASX (AUD): Pro Medicus Limited (PME)

Last Price

107.92

Today's Change

+0.71 (0.66%)

Day's Change

107.71 - 110.25

Trading Volume

149,936

Overview

Market Cap

11 Billion

Shares Outstanding

104 Million

Avg Volume

336,337

Avg Price (50 Days)

100.90

Avg Price (200 Days)

88.35

PE Ratio

163.52

EPS

0.66

Earnings Announcement

15-Feb-2024

Previous Close

107.21

Open

108.29

Day's Range

107.71 - 110.25

Year Range

58.6 - 111.885

Trading Volume

149,936

Price Change Highlight

1 Day Change

0.66%

5 Day Change

6.50%

1 Month Change

12.18%

3 Month Change

7.16%

6 Month Change

38.71%

Ytd Change

12.07%

1 Year Change

70.84%

3 Year Change

131.14%

5 Year Change

476.80%

10 Year Change

12747.62%

Max Change

9284.35%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Health Information Services

Description:

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company provides its products under the Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease names. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment